Multiple Myeloma
News
More evidence links increased BMI to higher multiple myeloma risk
MM risk rose almost 30% for every 5 kg/m2 increase in young adult BMI.
News
In myeloma, third ASCT is a viable option
The analysis identifies relapse-free interval as a prognostic factor.
Best Practices
Treatment and Management of Multiple Myeloma
A panel discussion of the challenges and standards of care for managing patients with multiple myeloma.
News
Meningococcal Arthritis Masking as Possible Myeloma
Clinicians reveal the importance of screening for an underlying impaired immune response when patients present with rare symptoms.
News
Continue to opt for HDT/ASCT for multiple myeloma
A systematic review and meta-analysis confirms that HDT/ASCT is still the best option for newly-diagnosed multiple myeloma.
News
Anti-BCMA CAR T-cell therapy being fast tracked at FDA
The CAR T-cell therapy bb2121 was granted breakthrough therapy designation by the Food and Drug Administration, speeding its review process.
Conference Coverage
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and more
ASH President Kenneth C. Anderson, MD, and ASH Secretary Robert A. Brodsky, MD, gave a preview of four practice-changing studies.
News
Cyclophosphamide after transplant reduced GVHD in myeloma patients
Anticancer agents may be more active after transplantation than before, researchers suggested.
Conference Coverage
Tailored approaches to relapsed/recalcitrant myeloma found within NCCN guidelines
SAN FRANCISCO – The approach to relapsed/refractory multiple myeloma (MM) has to be tailored patient by patient based on the biology of the...
Conference Coverage
New antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65
MADRID – Patients with refractory/relapsed multiple myeloma had similar rates of progression-free survival whether they were younger than age 65...
